Caeregen Therapeutics

About:

Caeregen Therapeutics is committed to finding and creating innovative medicinal solutions.

Top Investors: National Institutes of Health, National Eye Institute

Description:

Caeregen Therapeutics is committed to finding and developing innovative pharmacological therapies that restore damaged and sick tissues and protect them by reactivating the signaling pathways that are involved in healthy cellular and tissue development.

Total Funding Amount:

$1.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Chapel Hill, North Carolina, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)caeregen.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-07-17

IPO Status:

Private

Industries: